Dyslipidemia and coronary heart disease

Current Opinion in Lipidology

Volumn 7, Issue 4, 1996, Pages 179-182

  Vega, Gloria Lena ^a   Sirtori, Cesare ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; STATIN;

AGE; DIET; DISEASE ASSOCIATION; DYSLIPIDEMIA; ETHNOLOGY; FEMALE; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MALE; OBESITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY;

EID: 0029741866     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199608000-00001     Document Type: Short Survey

References (9)

1. The Scandinavian Simvastatin Survival Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994, 344: 1383-1389.
2. Shephard J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995, 333:1301-1307.
3. Endo A: The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res 1992, 33:1569-1582.
4. Grundy SM, Vega GL, Garg A: Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in various forms of dyslipidemia. Am J Cardiol 1990, 66:31A-38B.
5. Vega GL, Grundy SM: Lipoprotein responses to treatment with lovastatin, gemfibrozil, and nicotinic acid in normolipidemic patients with hypoalphalipoproteinemia. Arch Intern Med 1994, 154:73-82.
6. Vega GL, Grundy SM: Management of primary mixed hyperlipidemia with lovastatin. Arch Intern Med 1990, 150:1313-1319.
7. Vega GL, Grundy SM: Influence of lovastatin therapy on metabolism of low density lipoproteins in mixed hyperlipidaemia. J Intern Med 1991, 230:341-350.
8. Vega GL, Toto R D, Grundy SM: Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia. Kidney Int 1995, 47:579-586.
9. Davigon J, Roederer G, Montigny M, Hayden MR, Tan MH, Connelly PW, Hegele R, McPherson R, Lupien PJ, Gegne C et al.: Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia. Am J Cardiol 1994, 73:339-345.